Endoscopic ultrasound as an early diagnostic tool for primary sclerosing cholangitis: a prospective pilot study

Background and study aims: Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease, which typically affects middle-aged men and is frequently associated with inflammatory bowel disease. Early recognition and accurate diagnosis remains a clinical challenge. Invasive diagnostic procedures, such as endoscopic retrograde cholangiography or liver biopsy are needed when magnetic resonance cholangiopancreatography remains inconclusive. As these procedures are associated with significant risks, the current study sought to determine whether endoscopic ultrasound (EUS) of the biliary tract is a useful diagnostic tool in cases of suspected PSC.

Patients and methods: In a prospective pilot study, 138 patients presenting with chronic cholestatic hepatopathy were screened and 32 patients with possible PSC were evaluated further. In addition to all routine measures, EUS was included in the diagnostic work-up. The following parameters were evaluated and compared with the definitive diagnosis: wall thickening ( ≥ 1.5 mm), irregular wall structure, significant changes of caliber of the common bile duct, and perihilar lymphadenopathy.

Results: In the 138 patients screened, a PSC prevalence of 13 % was found. Of the 32 patients included in the study, 17 had large-duct PSC diagnosed. When two of the aforementioned four parameters showed PSC-like features, sensitivity and specificity of predicting PSC were 76.4 % and 100 %, with positive and negative predictive values of 100 % and 79 %, respectively. In four patients presenting with strictly intrahepatic disease, EUS was not diagnostic.

Conclusions: EUS proved to be a valuable tool in suspected PSC and accurately predicted extrahepatic disease. EUS should be evaluated further as an early procedure in routine diagnostic measurements. This approach promises a significant improvement in disease detection as well as a reduction in high risk invasive procedures.

• References

• 1 Tischendorf JJ, Hecker H, Kruger M et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007; 102: 107-114
• 2 Lutz HH, Tischendorf JJ. Management of primary sclerosing cholangitis. World J Hepatol 2011; 3: 137-141
• 3 Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-933
• 4 Terjung B, Worman HJ. Anti-neutrophil antibodies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001; 15: 629-642
• 5 De Riva V, Celadin M, Pittoni M et al. What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease?. Liver Int 2009; 29: 865-870
• 6 Lankisch TO, Metzger J, Negm AA et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 2011; 53: 875-884
• 7 Dave M, Elmunzer BJ, Dwamena BA et al. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 2010; 256: 387-396
• 8 Beuers U, Boberg KM, Chapman MH et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267
• 9 Moff SL, Kamel IR, Eustace J et al. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc 2006; 64: 219-223
• 10 Weber C, Kuhlencordt R, Grotelueschen R et al. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis. Endoscopy 2008; 40: 739-745
• 11 Mesenas S, Vu C, Doig L et al. Duodenal EUS to identify thickening of the extrahepatic biliary tree wall in primary sclerosing cholangitis. Gastrointest Endosc 2006; 63: 403-408
• 12 Rustemovic N, Cukovic-Cavka S, Opacic M et al. Endoscopic ultrasound elastography as a method for screening the patients with suspected primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2010; 22: 748-753
• 13 Schulte SJ, Baron RL, Teefey SA et al. CT of the extrahepatic bile ducts: wall thickness and contrast enhancement in normal and abnormal ducts. AJR Am J Roentgenol 1990; 154: 79-85
• 14 Kirchner GI, Tischendorf JJ, Bleck J et al. Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma. Scand J Gastroenterol 2008; 43: 1366-1370
• 15 Hirche TO, Russler J, Braden B et al. Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int J Colorectal Dis 2004; 19: 586-594
• 16 Singal AK, Stanca CM, Clark V et al. Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature. Hepatol Int 2011; 5: 808-813
• 17 Tischendorf JJ, Geier A, Trautwein C. Current diagnosis and management of primary sclerosing cholangitis. Liver Transpl 2008; 14: 735-746
• 18 Broome U, Olsson R, Loof L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-615
• 19 Lindor KD. Immunoglobulin g4-associated autoimmune cholangiopathy. Gastroenterol Hepatol (N Y) 2011; 7: 259-261
• 20 Kalaitzakis E, Levy M, Kamisawa T et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol 2011; 9: 800-803. e2
• 21 Kamisawa T, Anjiki H, Takuma K et al. Endoscopic approach for diagnosing autoimmune pancreatitis. World J Gastrointest Endosc 2010; 2: 20-24
• 22 Tischendorf JJ, Meier PN, Strassburg CP et al. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2006; 41: 1227-1234